Page last updated: 2024-08-23

paclitaxel and Myeloproliferative Disorders

paclitaxel has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Costa, FF; da Silva Santos Duarte, A; de Melo Campos, P; Favaro, P; Lazarini, M; Lorand-Metze, I; Machado-Neto, JA; Saad, ST; Traina, F	1

Other Studies

1 other study(ies) available for paclitaxel and Myeloproliferative Disorders

Article	Year
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells. Oncotarget, 2015, Oct-06, Volume: 6, Issue:30 Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Leukemia, Erythroblastic, Acute; Microscopy, Confocal; Middle Aged; Mutation, Missense; Myeloproliferative Disorders; Nitriles; Paclitaxel; Pyrazoles; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Stathmin; Tubulin Modulators; Young Adult	2015

Article

Year

Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells.

Oncotarget, 2015, Oct-06, Volume: 6, Issue:30

Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Leukemia, Erythroblastic, Acute; Microscopy, Confocal; Middle Aged; Mutation, Missense; Myeloproliferative Disorders; Nitriles; Paclitaxel; Pyrazoles; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Stathmin; Tubulin Modulators; Young Adult

2015